Search

Displaying results 3911 - 3920 of 5419 in total
  1. Drug

    MLN2704

    go.drugbank.com/drugs/DB06513
    Investigational

    A Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.

  2. Drug

    Lanimostim

    go.drugbank.com/drugs/DB06559
    Experimental

  3. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  4. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  5. Drug

    Aldoxorubicin

    go.drugbank.com/drugs/DB06013
    Investigational

    Aldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.

  6. Drug

    R-1487

    go.drugbank.com/drugs/DB06518
    Experimental

  7. Drug

    Lenograstim

    go.drugbank.com/drugs/DB13144
    ApprovedWithdrawn

    Lenograstim is a recombinant granulocyte colony-stimulating factor used as an immunostimulating agent.

  8. Drug

    NM3086

    go.drugbank.com/drugs/DB17719
    Experimental

    NM3086 is a recombinant, humanized, aglycosylated, IgG1-kappa anti-properdin monoclonal antibody being developed by Novelmed Therapeutics Inc.[L46193]

  9. Drug

    Oxomemazine

    go.drugbank.com/drugs/DB13820
    Investigational

    Oxomemazine is a phenothiazine derivative.

    Categories: Antihistamines for Systemic Use
  10. Drug

    2-deoxyglucose

    go.drugbank.com/drugs/DB08831
    Investigational

    The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately … With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to penetrate cells.